For me, diversity is also about attitudes, mindsets, viewpoints and ways of thinking that promote inclusivity that brings out the best features in the human experience.”
Eric Bloch Endowed Chair
Department of Materials Design and Innovation
UB’s School of Engineering and Applied Sciences (SEAS) is committed to creating an inclusive and diverse community—one that will enrich engineering education and empower our students to achieve their goals.
Our Diversity in SEAS Partnership Program participants join us in the commitment to help build a pipeline for talented minority engineering students to become future employees.
Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and systems.
Moog’s high-performance systems control military and commercial aircraft, satellites and space vehicles, launch vehicles, missiles, automated industrial machinery, and marine and medical equipment.
National Grid is one of the largest investor-owned energy companies in the U.S. – serving more than 20 million customers throughout New York, Massachusetts, and Rhode Island.
National Grid is at the heart of one of the greatest challenges facing our society – transforming our electricity and natural gas networks with smarter, cleaner, and more resilient energy solutions to meet the goal of reducing greenhouse gas emissions.
National Grid works with stakeholders to promote the development and implementation of more sustainable, innovative, and affordable energy solutions and is committed to delivering safe and reliable energy to customers and the communities they serve.
National Fuel is a diversified energy company headquartered in Williamsville, NY, that operates an integrated collection of natural gas & oil assets across five segments: Exploration & Production, Pipeline & Storage, Gathering, Utility, Energy Marketing.
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.
Founded and led for over 30 years by physician-scientists, Regeneron’s unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, all of which were homegrown in their laboratories.
Regeneron is accelerating and improving the traditional drug development process through their proprietary VelociSuite® technologies, which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
Want to support UB STEM Diversity Programs? Contact Erin Uppington today about corporate sponsorship opportunities.
Support us with a gift to the SEAS Justice, Equity, Diversity, Inclusion (JEDI) Initiatives Fund.